VEGFA and neoplasm: Upon intravenous administration, the nanoparticles seemed to successfully deliver siRNA to the U87-MG glioblastoma cells implanted under the skin of nude mice, silencing the expression of vascular endothelial growth factor (VEGF), and thus reducing capillary density at the tumor site more efficiently than just polyplexes.